Tamás Pintér
YOU?
Author Swipe
View article: Guide to 177Lu-Prostate Specific Membrane Antigen Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer in Slovakia
Guide to 177Lu-Prostate Specific Membrane Antigen Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer in Slovakia Open
Radioligand therapy with 177 Lu-Prostate Specific Membrane Antigen is a very promising treatment option for patients with prostate cancer. In the past ten years it started to be used as one of the final options in patients with metastatic,…
View article: Recurrent pneumothoraces caused by a high-grade lung carcinoma with trophoblastic differentiation: a case report
Recurrent pneumothoraces caused by a high-grade lung carcinoma with trophoblastic differentiation: a case report Open
Gestational trophoblastic neoplasms are tumors that occur during pregnancy, while non-gestational trophoblastic tumors have a similar histology but are present outside of gestation. Literature reports several cases of non-gestational troph…
View article: Application of comprehensive molecular genetic profiling in precision cancer medicine, Hungarian experiences
Application of comprehensive molecular genetic profiling in precision cancer medicine, Hungarian experiences Open
Recent developments in molecular genetic testing methods (e.g. next-generation sequencing [NGS]-panels) largely accelerated the process of finding the most appropriate targeted therapeutic intervention for cancer patients based on molecula…
View article: Ewing Sarcoma of the Larynx with Thyroid Cartilage Destruction: A Case Report
Ewing Sarcoma of the Larynx with Thyroid Cartilage Destruction: A Case Report Open
Ewing sarcoma of the larynx is extremely rare, only a few number of cases have been reported. In this report, we describe a case of extraskeletal Ewing sarcoma of the larynx with thyroid cartilage destruction. Laryngoscope , 134:4577–4581,…
View article: Adjuvant <i>nab</i> -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
Adjuvant <i>nab</i> -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial Open
PURPOSE This randomized, open-label trial compared the efficacy and safety of adjuvant nab-paclitaxel + gemcitabine with those of gemcitabine for resected pancreatic ductal adenocarcinoma (ClinicalTrials.gov identifier: NCT01964430 ). METH…
View article: Biomarkers Derived From Routine Blood Cell Counts Differentially Predict Disease-Free and Overall Survival After Neoadjuvant Treatment of Triple-Negative Breast Cancer
Biomarkers Derived From Routine Blood Cell Counts Differentially Predict Disease-Free and Overall Survival After Neoadjuvant Treatment of Triple-Negative Breast Cancer Open
In recent years some serologic parameters emerged as potential prognostic factors. The neutrophil-to-lymphocyte ratio (NLR) has the most evidence; however, other serologic factors were also reported. The only established systemic treatment…
View article: A Single Centre Experience with Phenotype Dependent Perioperative Chemotherapy for Primary Breast Cancer
A Single Centre Experience with Phenotype Dependent Perioperative Chemotherapy for Primary Breast Cancer Open
Background: Standard adjuvant or neo-adjuvant chemotherapy of primary breast cancers consists of docetaxel and the combination of anthracyclin-cyclophosphamide in two steps. According to international literature, the neo-adjuvant treatment…
View article: Non-Neutropenic Sepsis in Cancer Patients: The Luminal Obstruction Syndrome
Non-Neutropenic Sepsis in Cancer Patients: The Luminal Obstruction Syndrome Open
Background: Neutropenic sepsis is a frequent complication of cytotoxic chemotherapy delivered for cancer patients. Its management is well determined by clinical guidelines. Non-neutropenic sepsis is another potential complication in cancer…